ITHACA, N.Y. — Rheonix, Inc., a developer of fully automated molecular testing solutions, has received a Small Business Innovation Research (SBIR) Phase II grant, under Award Number R44DE024456-02, from the National Institute of Dental & Craniofacial Research (NIDCR) of the National Institutes of Health (NIH). The grant will allow Rheonix to complete the development of […]
Alameda, Calif. –– Singulex, Inc., the developer and leading provider of Single Molecule Counting technology for clinical diagnostics and scientific discovery, today announced a collaboration agreement with CHDI Foundation, a nonprofit biomedical research organization exclusively dedicated to rapidly developing drugs that will slow the progression of Huntington’s disease (HD). The collaboration will use Singulex’s proprietary […]
Cardiovascular testing disease laboratories Health Diagnostics Laboratory Inc. (HDL), of Richmond, Virginia, and Singulex Inc., of Alameda, California, have agreed to resolve allegations that they violated the False Claims Act by paying remuneration to physicians in exchange for patient referrals and billing federal health care programs for medically unnecessary testing, the Department of Justice announced […]
SUNNYVALE, Calif.– Cepheid (Nasdaq: CPHD) today announced that it has appointed Mr. Ilan Daskal to the position of Executive Vice President and Chief Financial Officer, effective April 9, 2015. Mr. Daskal will assume responsibility for worldwide finance operations, information technology, and investor relations. Mr. Daskal brings more than twenty years of finance experience to Cepheid, […]
Ann Arbor, MI –– Rubicon Genomics, Inc., a provider of pre-analytical reagent kits to improve the performance of genomic analytical platforms, today announced that it has extended its clinical supply agreement with Agendia for use of its TransPLEX® whole genome RNA amplification technology. Agendia uses Rubicon’s TransPLEX C-WTA kits for the analysis of FFPE (formalin-fixed, […]
CANOGA PARK, Calif. — One Lambda, Inc., part of Thermo Fisher Scientific and leading producer of in vitro diagnostic products for the HLA transplant community, today announced the availability of the only FDA cleared and CE marked assay for detecting HNA-3, as well as HLA. What’s more, the new LABScreen® Multi screening kit is capable […]
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the preliminary results of the tender offer by Roche Holdings, Inc., its wholly owned subsidiary, for up to 15,604,288 shares of common stock of Foundation Medicine, Inc. (NASDAQ: FMI) at USD 50.00 per share in cash. The tender offer expired at 12:00 midnight, New York City time, […]
LEXINGTON, Mass. -– N-of-One, Inc., the leader in clinical interpretation for precision medicine in oncology, today announced that the company will provide the clinical interpretation for all genomic tests to be conducted for the New England Veterans Integrated Service Network (VISN 1) Precision Oncology Program. N-of-One will work closely with Personalis and Personal Genome Diagnostics […]
AUSTIN, Texas — Luminex Corporation (NASDAQ: LMNX) today announced the launch of the NxTAG™ Respiratory Pathogen Panel (RUO). The NxTAG Respiratory Pathogen Panel is the only respiratory assay that enables laboratories to both simultaneously detect 22 respiratory pathogens in a single closed tube system and accommodate the higher throughput required to respond to seasonal changes […]
BILLERICA, Mass.– Bruker (NASDAQ: BRKR) today announced that it has received 510(k) clearance from the US Food and Drug Administration for library and methods expansion for the MALDI Biotyper CA System, sold in the United States for clinical microbiology. In November 2013, Bruker received FDA 510(k) clearance for a first claim for the MALDI Biotyper […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
